首页> 外文期刊>The Southeast Asian journal of tropical medicine and public health >The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice.
【24h】

The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice.

机译:编码日本血吸虫中国菌株磷酸三糖磷酸异构酶的DNA疫苗对感染的BALB / C小鼠的保护性免疫。

获取原文
获取原文并翻译 | 示例
           

摘要

The development of a DNA vaccine for schistosomiasis japonica and testing the protective efficacy after challenge in BALB/c mice were performed. Thirty-nine female BALB/c mice were divided into three groups. Each mouse of the control group was injected intramuscularly with 100 microg of pcDNA3.1 DNA. In the TPI group, each mouse was injected with 100 microg of pcDNA3.1-SjCTPI DNA. The TPI+IL-12 group was injected with 100 microg of pcDNA3.1-SjCTPI DNA and 100 microg of the mixture of pcDNA3.1-P35 and pcDNA3.1-P40 DNA. Each mouse was immunized three times at two-week intervals and challenged with 45 cercariae of Schistosoma japonicum Chinese strain four weeks post-immunization. Then the mice were sacrificed and perfused at 45 days after challenge; the recovered worms and hepatic eggs were counted. Cytotoxic T lymphoctye (CTL) activity mediated by SjCTPI was detected with the 51Cr release assay. ELISA was performed for the detection of anti-rTPI antibodies. Anti-rTPI antibody detection with ELISA after immunization showed ten serum samples from the control group were negative, five of ten serum samples from the TPI group were weakly positive, six of ten from the TPI+IL-12 group were also weakly positive. The CTL activity of the control group was 9.1%, while CTL activities of the TPI group and the TPI+IL-12 group were 27.6% and 54.4%, respectively. The worm and egg reduction rates of TPI group and the TPI+IL-12 group were 30.2%, 52.9%, 32.7%, and 47.0%, respectively in comparison with the control group. This study further proved the possibility of the SjCTPI DNA vaccine as a potential DNA vaccine for schistosomiasis.
机译:进行了日本血吸虫病DNA疫苗的开发并测试了BALB / c小鼠攻击后的保护功效。将39只雌性BALB / c小鼠分为三组。对照组的每只小鼠肌肉内注射100微克的pcDNA3.1 DNA。在TPI组中,每只小鼠注射100微克pcDNA3.1-SjCTPI DNA。向TPI + IL-12组注射100微克pcDNA3.1-SjCTPI DNA和100​​微克pcDNA3.1-P35和pcDNA3.1-P40 DNA的混合物。每只小鼠以两周的间隔进行三次免疫,并在免疫后四周用日本血吸虫中国菌株的45尾strain进行攻击。然后在攻击后45天处死小鼠并灌注。对回收的蠕虫和肝卵进行计数。用51Cr释放测定法检测到SjCTPI介导的细胞毒性T淋巴结(CTL)活性。进行ELISA以检测抗rTPI抗体。免疫后通过ELISA进行的抗rTPI抗体检测显示,对照组的十份血清样本为阴性,TPI组的十份血清样本中有五份为弱阳性,TPI + IL-12组的十份血清也为弱阳性。对照组的CTL活性为9.1%,而TPI组和TPI + IL-12组的CTL活性分别为27.6%和54.4%。与对照组相比,TPI组和TPI + IL-12组的蠕虫和卵减少率分别为30.2%,52.9%,32.7%和47.0%。这项研究进一步证明了SjCTPI DNA疫苗作为血吸虫病的潜在DNA疫苗的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号